COVISHIELD Vaccine–Induced Ocular Stevens-Johnson Syndrome: A Case Report
Cornea Open · 2022
DOI: 10.1097/coa.0000000000000002 ↗Kurz gefasst
Fallbericht in der Zeitschrift Cornea Open, 2022. Verfasst von Shweta Singh und 2 weiteren Autor:innen. Die Arbeit nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Stevens-Johnson syndrome (SJS) is an acute inflammatory vesiculobullous reaction of the skin and mucosa. The involvement of the ocular mucosa in these cases leads to ocular SJS. The most commonly reported etiological agents for SJS are drugs, viral infections, and vaccination. Here, we present the first ever reported case of ocular SJS occurring secondary to COVISHIELD vaccination, wherein a 62-year-old had an episode of acute SJS within a week of the COVISHIELD booster dose. She presented to us 6 months after the acute episode with infectious keratitis in the right eye and descemetocele in the left eye in chronic SJS with severe bilateral lid keratinization in all 4 lids and healed skin pigmentation typical of SJS sequelae.
Zitieren
APA
Singh, S., Gupta, N., & Sangwan, V. (2022). COVISHIELD Vaccine–Induced Ocular Stevens-Johnson Syndrome: A Case Report. Cornea Open. https://doi.org/10.1097/coa.0000000000000002
Vancouver
Singh S, Gupta N, Sangwan V. COVISHIELD Vaccine–Induced Ocular Stevens-Johnson Syndrome: A Case Report. Cornea Open. 2022. doi:10.1097/coa.0000000000000002
BibTeX
@article{Singh2022,
author = {Singh, Shweta and Gupta, Nidhi and Sangwan, Virender},
title = {COVISHIELD Vaccine–Induced Ocular Stevens-Johnson Syndrome: A Case Report},
journal = {Cornea Open},
year = {2022},
doi = {10.1097/coa.0000000000000002}
}
EUVIMED